This cohort study was performed in approximately 280 predominantly community-based US cancer clinics and included patients aged 18 years or older who had stage IIIB, IIIC, or IV non-small cell lung cancer.
[JAMA Oncology]
Home Newsletters Human Immunology News Association Between Age and Survival Trends in Advanced Non–Small Cell Lung Cancer...
